This review highlights Chagas disease as a major neglected tropical cardiomyopathy, emphasizing its significant burden in Latin America and the urgent need for new research and treatments.
No takes yet. Share an insight, caveat, or question.
Chagas cardiomyopathy warrants greater clinical awareness in at-risk populations; leaves open urgent need for new drug development and trials.
Yacoub et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: